Skip to content

In the BioHarmony Drug Report Database

Nateglinide

Starlix (nateglinide) is a small molecule pharmaceutical. Nateglinide was first approved as Starlix on 2000-12-22. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus.
Trade Name Starlix
Common Name Nateglinide
Indication type 2 diabetes mellitus
Drug Class Antidiabetic, SGLT2 inhibitors, not phlorozin derivatives
Nateglinide
Get full access now